|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.26 |
5.85 |
-47.99 |
4 |
5 |
1 |
72 |
350.49 |
7 |
↓
|
Mid
Mid (pH 6-8)
|
2.26 |
6.58 |
-83.64 |
5 |
5 |
2 |
74 |
351.498 |
7 |
↓
|
Lo
Low (pH 4.5-6)
|
2.26 |
7.64 |
-159.81 |
6 |
5 |
3 |
75 |
352.506 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 2 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.26 |
6.23 |
-51.25 |
4 |
5 |
1 |
72 |
350.49 |
7 |
↓
|
Mid
Mid (pH 6-8)
|
2.26 |
6.94 |
-96.56 |
5 |
5 |
2 |
74 |
351.498 |
7 |
↓
|
Lo
Low (pH 4.5-6)
|
2.26 |
7.64 |
-163.81 |
6 |
5 |
3 |
75 |
352.506 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ACE-1-E |
Angiotensin-converting Enzyme (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
193 |
0.30 |
Binding ≤ 10μM
|
CXCR4-1-E |
C-X-C Chemokine Receptor Type 4 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
CXCR4-1-E |
C-X-C Chemokine Receptor Type 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.37 |
Functional ≤ 10μM
|
ENV-1-V |
Envelope Glycoprotein Gp160 (cluster #1 Of 2), Viral |
Viruses |
2 |
0.39 |
Binding ≤ 10μM
|
Z50607-1-O |
Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other |
Other |
5 |
0.37 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.62 |
9.78 |
-81.92 |
3 |
7 |
2 |
63 |
422.577 |
5 |
↓
|
Hi
High (pH 8-9.5)
|
2.62 |
6.86 |
-13.96 |
1 |
7 |
0 |
60 |
420.561 |
5 |
↓
|
Mid
Mid (pH 6-8)
|
2.62 |
7.56 |
-73.43 |
3 |
7 |
2 |
63 |
422.577 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CXCR4-1-E |
C-X-C Chemokine Receptor Type 4 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
Z50607-1-O |
Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other |
Other |
1 |
0.36 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.93 |
16.04 |
-233.28 |
5 |
7 |
4 |
61 |
483.749 |
17 |
↓
|
Hi
High (pH 8-9.5)
|
2.93 |
13.05 |
-71.47 |
3 |
7 |
2 |
59 |
481.733 |
17 |
↓
|
Hi
High (pH 8-9.5)
|
2.93 |
13.54 |
-40.73 |
2 |
7 |
1 |
57 |
480.725 |
17 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 27 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.04 |
2.29 |
-156.31 |
9 |
8 |
3 |
89 |
505.82 |
4 |
↓
|
Hi
High (pH 8-9.5)
|
2.94 |
7.04 |
-11.84 |
1 |
10 |
0 |
126 |
459.499 |
7 |
↓
|
|
|
Analogs
-
37996312
-
-
37998969
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CXCR4-1-E |
C-X-C Chemokine Receptor Type 4 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
CXCR4-1-E |
C-X-C Chemokine Receptor Type 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.55 |
Functional ≤ 10μM |
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
5 |
0.53 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.65 |
8.37 |
-34.67 |
3 |
4 |
1 |
51 |
291.378 |
6 |
↓
|
Hi
High (pH 8-9.5)
|
0.51 |
2.82 |
-60.28 |
3 |
13 |
-1 |
183 |
531.446 |
7 |
↓
|
Mid
Mid (pH 6-8)
|
2.65 |
8.84 |
-71.14 |
4 |
4 |
2 |
52 |
292.386 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CXCR4-1-E |
C-X-C Chemokine Receptor Type 4 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
112 |
0.32 |
Binding ≤ 10μM
|
CXCR4-1-E |
C-X-C Chemokine Receptor Type 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
10 |
0.37 |
Functional ≤ 10μM
|
Z50607-2-O |
Human Immunodeficiency Virus 1 (cluster #2 Of 10), Other |
Other |
9 |
0.38 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Hi
High (pH 8-9.5)
|
0.24 |
5.75 |
-168.11 |
7 |
6 |
3 |
75 |
413.634 |
6 |
↓
|
Hi
High (pH 8-9.5)
|
0.24 |
4.34 |
-107.26 |
6 |
6 |
2 |
70 |
412.626 |
6 |
↓
|
Mid
Mid (pH 6-8)
|
0.24 |
5.03 |
-177.16 |
7 |
6 |
3 |
78 |
413.634 |
6 |
↓
|
|
|
Analogs
-
3978074
-
-
4245659
-
-
4245660
-
-
4467870
-
-
11592709
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 37 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
KITH-1-E |
Thymidine Kinase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7000 |
0.38 |
Binding ≤ 10μM
|
CXCR4-1-E |
C-X-C Chemokine Receptor Type 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.60 |
Functional ≤ 10μM
|
Z80295-1-O |
MT4 (Lymphocytes) (cluster #1 Of 1), Other |
Other |
20 |
0.57 |
Binding ≤ 10μM
|
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 4), Other |
Other |
4 |
0.62 |
Functional ≤ 10μM
|
Z102020-1-O |
Porcine Endogenous Retrovirus (cluster #1 Of 1), Other |
Other |
23 |
0.56 |
Functional ≤ 10μM
|
Z50459-2-O |
Leishmania Donovani (cluster #2 Of 8), Other |
Other |
3400 |
0.40 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
7 |
0.60 |
Functional ≤ 10μM
|
Z50594-1-O |
Mus Musculus (cluster #1 Of 9), Other |
Other |
46 |
0.54 |
Functional ≤ 10μM
|
Z50607-1-O |
Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other |
Other |
9600 |
0.37 |
Functional ≤ 10μM
|
Z50609-1-O |
Simian Immunodeficiency Virus (cluster #1 Of 2), Other |
Other |
12 |
0.58 |
Functional ≤ 10μM
|
Z50658-1-O |
Human Immunodeficiency Virus 2 (cluster #1 Of 4), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM
|
Z50664-1-O |
Rauscher Murine Leukemia Virus (cluster #1 Of 1), Other |
Other |
23 |
0.56 |
Functional ≤ 10μM
|
Z50677-1-O |
Human Immunodeficiency Virus (cluster #1 Of 3), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM
|
Z50737-1-O |
Human Immunodeficiency Virus 3 (cluster #1 Of 1), Other |
Other |
40 |
0.55 |
Functional ≤ 10μM
|
Z80052-1-O |
C8166 (Leukemic T-cells) (cluster #1 Of 3), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM
|
Z80071-1-O |
CEM-0 (T-cell Leukemia) (cluster #1 Of 2), Other |
Other |
6 |
0.61 |
Functional ≤ 10μM
|
Z80073-1-O |
CEM-c113 (cluster #1 Of 1), Other |
Other |
6 |
0.61 |
Functional ≤ 10μM
|
Z80076-1-O |
CEM-SS (T-cell Leukemia) (cluster #1 Of 5), Other |
Other |
95 |
0.52 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
6180 |
0.38 |
Functional ≤ 10μM
|
Z80285-1-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #1 Of 4), Other |
Other |
6 |
0.61 |
Functional ≤ 10μM
|
Z80294-1-O |
MT2 (Lymphocytes) (cluster #1 Of 1), Other |
Other |
6 |
0.61 |
Functional ≤ 10μM
|
Z80295-2-O |
MT4 (Lymphocytes) (cluster #2 Of 8), Other |
Other |
10 |
0.59 |
Functional ≤ 10μM
|
Z80384-1-O |
PBL (Peripheral Blood Lymphocytes) (cluster #1 Of 1), Other |
Other |
29 |
0.56 |
Functional ≤ 10μM
|
Z80516-1-O |
SUP-T1 (cluster #1 Of 1), Other |
Other |
50 |
0.54 |
Functional ≤ 10μM |
Z80566-1-O |
U-937 (Histiocytic Lymphoma Cells) (cluster #1 Of 2), Other |
Other |
40 |
0.55 |
Functional ≤ 10μM
|
Z80683-1-O |
ATH8 Cell Line (cluster #1 Of 1), Other |
Other |
400 |
0.47 |
Functional ≤ 10μM
|
Z80688-1-O |
B(EBV+) Cell Line (cluster #1 Of 1), Other |
Other |
1 |
0.66 |
Functional ≤ 10μM
|
Z80721-1-O |
BxT Cell Line (cluster #1 Of 1), Other |
Other |
55 |
0.53 |
Functional ≤ 10μM
|
Z80737-1-O |
C3H/3T3 (Embryonic Fibroblast Cells) (cluster #1 Of 1), Other |
Other |
20 |
0.57 |
Functional ≤ 10μM
|
Z80760-1-O |
CFU-GM Cell Line (cluster #1 Of 1), Other |
Other |
1500 |
0.43 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
870 |
0.45 |
Functional ≤ 10μM
|
Z80897-1-O |
H9 (T-lymphoid Cells) (cluster #1 Of 2), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM |
Z81072-2-O |
Jurkat (Acute Leukemic T-cells) (cluster #2 Of 10), Other |
Other |
10 |
0.59 |
Functional ≤ 10μM
|
Z81223-1-O |
M Cell Line (cluster #1 Of 1), Other |
Other |
15 |
0.58 |
Functional ≤ 10μM
|
Z81247-7-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #7 Of 9), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM
|
Z80874-3-O |
CEM (T-cell Leukemia) (cluster #3 Of 4), Other |
Other |
700 |
0.45 |
ADME/T ≤ 10μM
|
Z80897-1-O |
H9 (T-lymphoid Cells) (cluster #1 Of 2), Other |
Other |
45 |
0.54 |
ADME/T ≤ 10μM
|
Q72547-1-V |
Human Immunodeficiency Virus Type 1 Reverse Transcriptase (cluster #1 Of 6), Viral |
Viruses |
6 |
0.61 |
Binding ≤ 10μM
|
Q72874-1-V |
Human Immunodeficiency Virus Type 1 Protease (cluster #1 Of 3), Viral |
Viruses |
6 |
0.61 |
Binding ≤ 10μM
|
Q72547-1-V |
Human Immunodeficiency Virus Type 1 Reverse Transcriptase (cluster #1 Of 1), Viral |
Viruses |
8 |
0.60 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.10 |
-3.76 |
-14.65 |
2 |
9 |
0 |
134 |
267.245 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CXCR4-1-E |
C-X-C Chemokine Receptor Type 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.38 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.63 |
7.89 |
-37.41 |
4 |
9 |
1 |
101 |
473.964 |
10 |
↓
|
Mid
Mid (pH 6-8)
|
2.63 |
10.17 |
-102.59 |
5 |
9 |
2 |
103 |
474.972 |
10 |
↓
|
Mid
Mid (pH 6-8)
|
2.63 |
7.49 |
-9.96 |
3 |
9 |
0 |
100 |
472.956 |
10 |
↓
|
|
|
Analogs
-
39908
-
-
17175067
-
-
17175068
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 35 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CXCR4-1-E |
C-X-C Chemokine Receptor Type 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
88 |
0.66 |
Functional ≤ 10μM
|
Z50606-1-O |
Hepatitis B Virus (cluster #1 Of 3), Other |
Other |
2300 |
0.53 |
Functional ≤ 10μM
|
Z50607-1-O |
Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other |
Other |
910 |
0.56 |
Functional ≤ 10μM
|
Z50624-1-O |
Human Adenovirus Type 2 (cluster #1 Of 1), Other |
Other |
3300 |
0.51 |
Functional ≤ 10μM
|
Z50658-2-O |
Human Immunodeficiency Virus 2 (cluster #2 Of 4), Other |
Other |
690 |
0.58 |
Functional ≤ 10μM
|
Z50677-1-O |
Human Immunodeficiency Virus (cluster #1 Of 3), Other |
Other |
800 |
0.57 |
Functional ≤ 10μM
|
Z80052-1-O |
C8166 (Leukemic T-cells) (cluster #1 Of 3), Other |
Other |
125 |
0.64 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
22 |
0.71 |
Functional ≤ 10μM
|
Z80076-1-O |
CEM-SS (T-cell Leukemia) (cluster #1 Of 5), Other |
Other |
50 |
0.68 |
Functional ≤ 10μM
|
Z80294-1-O |
MT2 (Lymphocytes) (cluster #1 Of 1), Other |
Other |
994 |
0.56 |
Functional ≤ 10μM
|
Z80295-2-O |
MT4 (Lymphocytes) (cluster #2 Of 8), Other |
Other |
300 |
0.61 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
70 |
0.67 |
Functional ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 8), Other |
Other |
3200 |
0.51 |
Functional ≤ 10μM |
Q72547-1-V |
Human Immunodeficiency Virus Type 1 Reverse Transcriptase (cluster #1 Of 6), Viral |
Viruses |
51 |
0.68 |
Binding ≤ 10μM
|
Q72547-1-V |
Human Immunodeficiency Virus Type 1 Reverse Transcriptase (cluster #1 Of 1), Viral |
Viruses |
31 |
0.70 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.06 |
-2.38 |
-18.62 |
3 |
6 |
0 |
90 |
211.221 |
2 |
↓
|
|